|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$37,574
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$2,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$2,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$750
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Targeting PML for therapy in leukemia-initiating cells
|
4R00CA139009-03
|
$249,000
|
$249,000
|
ITO, KEISUKE
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
The role of c-Maf in Stem cells in Leukemia
|
5F31CA162770-02
|
$42,232
|
$21,116
|
Okoye, Ujunwa
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-38
|
$101,749
|
$5,087
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
CD20-targeted IL-15 immunotherapeutic for B-cell malignancies
|
1R43CA174091-01
|
$257,303
|
$128,652
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
|
Charge sensitive optical detection for high throughput study of small molecules
|
1R21CA173205-01
|
$232,181
|
$232,181
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$34,032
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
Enhancing Treg Immune Reconstitution After Stem Cell Transplant
|
5R21CA149967-02
|
$311,709
|
$311,709
|
BOLLARD, CATHERINE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
DISCOVERY OF SMALL MOLECULAR ACTIVATORS OF NR4A ORPHAN NUCLEAR RECEPTORS
|
1R01CA160747-01A1
|
$324,738
|
$324,738
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk
|
1K23CA158148-01A1
|
$169,983
|
$169,983
|
Gramatges, Maria
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
SPORE in Lymphoma
|
2P50CA126752-06
|
$2,300,000
|
$851,000
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$1,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$2,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$88,043
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mechanism and Consequences of Telomere Dysfunction
|
5R01CA133249-05
|
$308,957
|
$154,479
|
Songyang, Zhou
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-14
|
$95,411
|
$4,771
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Novel Strategies for Treatment of Myeloproliferative Disorders
|
5R01CA131664-05
|
$342,168
|
$342,168
|
KHOSRAVI-FAR, ROYA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Targeting PML for leukemia therapy.
|
5R01CA142874-03
|
$455,022
|
$455,022
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Targeting Leukemic Stem Cells
|
5R01CA138211-05
|
$418,058
|
$418,058
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
4R00CA134743-03
|
$233,147
|
$186,518
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Oncogenic Notch Signaling
|
2P01CA119070-06A1
|
$1,088,030
|
$663,698
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
$13,707
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$20,295
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
$931,154
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
$114,310
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B Human Specimen Repositories
|
5U24CA114725-08
|
$1,150,236
|
$575,118
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Enabling Technologies for MRI-Guided Prostate Interventions
|
5R01CA111288-07
|
$572,897
|
$572,897
|
TEMPANY, CLARE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-03
|
$131,854
|
$1,319
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
|
Mapping the transcriptional regulatory circuits of human hematopoiesis
|
1F32CA168253-01
|
$47,114
|
$47,114
|
Cheng, Christine
|
BROAD INSTITUTE, INC.
|
|
|
Broad Institute Center for Cancer Systems Biology
|
3U54CA112962-08S1
|
$44,814
|
$11,204
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
|
Broad Institute Center for Cancer Systems Biology
|
5U54CA112962-08
|
$2,155,481
|
$538,870
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-29
|
$728,213
|
$7,282
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-38
|
$354,850
|
$17,743
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Bcl-2 function on the endoplasmic reticulum
|
5R01CA085804-13
|
$284,448
|
$113,779
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
5U01CA062502-19
|
$594,035
|
$35,642
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S3
|
$4,849,180
|
$145,475
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S4
|
$74,396
|
$2,232
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Cell signaling as a leukemia biomarker
|
1R21CA158659-01A1
|
$204,885
|
$204,885
|
JACOBBERGER, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-23
|
$326,434
|
$3,264
|
Wilbur, Deborah
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
|
Pax5:Hematopoietic Transcription Factor Involved in ALL
|
5R01CA026038-33
|
$365,285
|
$365,285
|
Koeffler, H.
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
Exploiting synthetic lethality of hematopoietic lineage cells to develop novel ta
|
5R44CA141848-03
|
$905,570
|
$452,785
|
Bonneau, Kyle
|
CELLECTA, INC.
|
|
|
Molecular pathogenesis of MLL-AF4 leukemias
|
5R01CA140575-03
|
$350,219
|
$350,219
|
ARMSTRONG, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
The role of AF10 in normal and leukemic hematopoiesis
|
5K99CA154880-02
|
$155,532
|
$155,532
|
DESHPANDE, ANIRUDDHA
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
Autophagy and apoptosis in the response of c-KIT cancers to targeted therapy
|
5K08CA154782-02
|
$143,362
|
$71,681
|
GORDON, PETER
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
Discovery and Targeting of Apoptosis Resistance Mechanisms in High-Risk T-ALL
|
1R21CA167124-01
|
$189,225
|
$189,225
|
Gutierrez, Alejandro
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
7K08CA133103-05
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
The role of Hedgehog in hematopoiesis and leukemogenesis
|
5K08CA140723-03
|
$164,250
|
$164,250
|
Hofmann Zhang, Inga
|
CHILDREN'S HOSPITAL BOSTON
|
|
Total relevant funding to Leukemia for this search: $234,716,347
|
